Pathophysiology of cystic fibrosis lung disease

European Respiratory Monograph

Volumn 64, Issue , 2014, Pages 1-13

  Mall, Marcus A ^a,b   Boucher, Richard C ^c  

^a Heidelberg Translational Lung Research Center (TLRC)   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EPITHELIAL SODIUM CHANNEL;

AIRWAY OBSTRUCTION; ARTICLE; CHANNELOPATHY; CHLORIDE TRANSPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR GENE; DEHYDRATION; DISEASE MODEL; GENE; GENE MUTATION; HUMAN; ION TRANSPORT; MIXED INFECTION; MOLECULAR PATHOLOGY; MUCOCILIARY CLEARANCE; MUCOSTASIS; MUCUS; NONHUMAN; PH; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFECTION; RESPIRATORY TRACT INFLAMMATION; RESPIRATORY TRACT MUCOSA; VISCOSITY;

EID: 84905749581     PISSN: 1025448X     EISSN: 20756674     Source Type: Book Series    
DOI: 10.1183/1025448x.10008513     Document Type: Article

References (103)

1. Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003; 168: 918-951.
2. Tunney MM, Field TR, Moriarty TF, et al. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis. Am J Respir Crit Care Med 2008; 177: 995-1001.
3. Zuelzer WW, Newton WA. The pathogenesis of fibrocystic disease of the pancreas: a study of 36 cases with special reference to the pulmonary lesions. Pediatrics 1949; 4: 53-69.
4. Andersen DH. Cystic fibrosis of the pancreas and its relation to celiac disease. Am J Dis Child 1938; 56: 344-399.
5. Belessis Y, Dixon B, Hawkins G, et al. Early cystic fibrosis lung disease detected by bronchoalveolar lavage and lung clearance index. Am J Respir Crit Care Med 2012; 185: 862-873.
6. Hoo AF, Thia LP, Nguyen TT, et al. Lung function is abnormal in 3-month-old infants with cystic fibrosis diagnosed by newborn screening. Thorax 2012; 67: 874-881.
7. Sly PD, Brennan S, Gangell C, et al. Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening. Am J Respir Crit Care Med 2009; 180: 146-152.
8. Sly PD, Gangell CL, Chen L, et al. Risk factors for bronchiectasis in children with cystic fibrosis. N Engl J Med 2013; 368: 1963-1970.
9. Stahl M, Joachim C, Blessing K, et al. Multiple breath washout is feasible in the clinical setting and detects abnormal lung function in infants and young children with cystic fibrosis. Respiration2014 [In press DOI: 10. 1159/000357075].
10. Wielputz MO, Puderbach M, Kopp-Schneider A, et al. Magnetic resonance imaging detects changes in structure and perfusion, and response to therapy in early cystic fibrosis lung disease. Am J Respir Crit Care Med2014 [In press DOI: 10. 1164/rccm. 201309-1659OC].
11. Matthews LM, Spector S, Lemm J, et al. Studies on pulmonary secretions. Am Rev Respir Dis 1963; 88: 199-204.
12. Regnis JA, Robinson M, Bailey DL, et al. Mucociliary clearance in patients with cystic fibrosis and in normal subjects. Am J Respir Crit Care Med 1994; 150: 66-71.
13. de Jong PA, Nakano Y, Hop WC, et al. Changes in airway dimensions on computed tomography scans of children with cystic fibrosis. Am J Respir Crit Care Med 2005; 172: 218-224.
14. Esterly JR, Oppenheimer EH. Cystic fibrosis of the pancreas: structural changes in peripheral airways. Thorax 1968; 23: 670-675.
15. Wielputz MO, Weinheimer O, Eichinger M, et al. Pulmonary emphysema in cystic fibrosis detected by densitometry on chest multidetector computed tomography. PLoS One 2013; 8: e73142.
16. Rommens JM, Iannuzzi B-SK, Drumm ML, et al. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science 1989; 245: 1059-1065.
17. Riordan JR, Rommens JM, Kerem B-S, et al. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989; 245: 1066-1072.
18. Kerem B, Rommens JM, Buchanan JA, et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989; 245: 1073-1080.
19. Smith JJ, Travis SM, Greenberg EP, et al. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell 1996; 85: 229-236.
20. Matsui H, Grubb BR, Tarran R, et al. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 1998; 95: 1005-1015.
21. Verkman AS, Song Y, Thiagarajah JR. Role of airway surface liquid and submucosal glands in cystic fibrosis lung disease. Am J Physiol Cell Physiol 2003; 284: C2-C15.
22. Pezzulo AA, Tang XX, Hoegger MJ, et al. Reduced airway surface pH impairs bacterial killing in the porcine cystic fibrosis lung. Nature 2012; 487: 109-113.
23. Pier GB, Grout M, Zaidi TS. Cystic fibrosis transmembrane conductance regulator is an epithelial cell receptor for clearance ofPseudomonas aeruginosafrom the lung. Proc Natl Acad Sci USA1997; 94: 12088-12093.
24. Di A, Brown ME, Deriy LV, et al. CFTR regulates phagosome acidification in macrophages and alters bactericidal activity. Nat Cell Biol 2006; 8: 933-944.
25. Painter RG, Valentine VG, Lanson NA Jr, et al. CFTR Expression in human neutrophils and the phagolysosomal chlorination defect in cystic fibrosis. Biochemistry 2006; 45: 10260-10269.
26. Teichgraber V, Ulrich M, Endlich N, et al. Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis. Nat Med 2008; 14: 382-391.
27. Heeckeren A, Walenga R, Konstan MW, et al. Excessive inflammatory response of cystic fibrosis mice to bronchopulmonary infection withPseudomonas aeruginosa. J Clin Invest 1997; 100: 2810-2815.
28. Grubb BR, Boucher RC. Pathophysiology of gene-targeted mouse models for cystic fibrosis. Physiol Rev 1999; 79: Suppl. 1, S193-S214.
29. Mall M, Grubb BR, Harkema JR, et al. Increased airway epithelial Na + absorption produces cystic fibrosis-like lung disease in mice. Nat Med 2004; 10: 487-493.
30. Zhou Z, Duerr J, Johannesson B, et al. ThebENaC-overexpressing mouse as a model of cystic fibrosis lung disease. J Cyst Fibros 2011; 10: Suppl. 2, S172-S182.
31. Livraghi-Butrico A, Kelly EJ, Klem ER, et al. Mucus clearance, MyD88-dependent and MyD88-independent immunity modulate lung susceptibility to spontaneous bacterial infection and inflammation. Mucosal Immunol 2012; 5: 397-408.
32. Stoltz DA, Meyerholz DK, Pezzulo AA, et al. Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth. Sci Transl Med 2010; 2: 29-31.
33. Riordan JR. CFTR function and prospects for therapy. Annu Rev Biochem 2008; 77: 701-726.
34. Anderson MP, Gregory RJ, Thompson S, et al. Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science 1991; 253: 202-205.
35. Smith JJ, Welsh MJ. cAMP stimulates bicarbonate secretion across normal, but not cystic fibrosis airway epithelia. J Clin Invest 1992; 89: 1148-1153.
36. Kreda SM, Mall M, Mengos A, et al. Characterization of wild-type andDF508 cystic fibrosis transmembrane regulator in human respiratory epithelia. Mol Biol Cell 2005; 16: 2154-2167.
37. Mall M, Kreda SM, Mengos A, et al. TheDF508 mutation results in loss of CFTR function and mature protein in native human colon. Gastroenterology 2004; 126: 32-41.
38. Knowles MR, Gatzy JT, Boucher RC. Increased biolelectric potential difference across respiratory epithelia in cystic fibrosis. N Engl J Med 1981; 305: 1489-1495.
39. Boucher RC, Stutts MJ, Knowles MR, et al. Na+ transport in cystic fibrosis respiratory epithelia. Abnormal basal rate and response to adenylate cyclase activation. J Clin Invest 1986; 78: 1245-1252.
40. Mall M, Bleich M, Greger R, et al. The amiloride inhibitable Na + conductance is reduced by CFTR in normal but not in cystic fibrosis airways. J Clin Invest 1998; 102: 15-21.
41. Mall MA. Role of the amiloride-sensitive epithelial Na + channel in the pathogenesis and as a therapeutic target for cystic fibrosis lung disease. Exp Physiol 2009; 94: 171-174.
42. Anantharam A, Palmer LG. Determination of epithelial Na + channel subunit stoichiometry from single-channel conductances. J Gen Physiol 2007; 130: 55-70.
43. Canessa CM, Schild L, Buell G, et al. Amiloride-sensitive epithelial Na + channel is made of three homologous subunits. Nature 1994; 367: 463-467.
44. Stutts MJ, Canessa CM, Olsen JC, et al. CFTR as a cAMP-dependent regulator of sodium channels. Science 1995; 269: 847-850.
45. Mall M, Hipper A, Greger R, et al. Wild type but notDF508 CFTR inhibits Na + conductance when coexpressed in Xenopusoocytes. FEBS Lett 1996; 381: 47-52.
46. Hopf A, Schreiber R, Mall M, et al. Cystic fibrosis transmembrane conductance regulator inhibits epithelial Na + channels carrying Liddle's syndrome mutations. J Biol Chem 1999; 274: 13894-13899.
47. Kunzelmann K, Mall M. Pharmacotherapy of the ion transport defect in cystic fibrosis. Clin Exp Pharmacol Physiol 2001; 28: 857-867.
48. Welsh MJ, Smith AE. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 1993; 73: 1251-1254.
49. Sosnay PR, Siklosi KR, Van Goor F, et al. Defining the disease liability of variants in the cystic fibrosis transmembrane conductance regulator gene. Nat Genet 2013; 45: 1160-1167.
50. Anderson MP, Welsh MJ. Calcium and cAMP activate different chloride channels in the apical membrane of normal and cystic fibrosis epithelia. Proc Natl Acad Sci 1991; 88: 6003-6007.
51. Knowles MR, Clarke LL, Boucher RC. Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis. N Engl J Med 1991; 325: 533-538.
52. Clarke LL, Grubb BR, Yankaskas JR, et al. Relationship of a non-cystic fibrosis transmembrane conductance regulator-mediated chloride conductance to organ-level disease in Cftr-/-mice. Proc Natl Acad Sci USA1994; 91: 479-483.
53. Mundhenk L, Johannesson B, Anagnostopoulou P, et al. mCLCA3 does not contribute to calcium-activated chloride conductance in murine airways. Am J Respir Cell Mol Biol 2012; 47: 87-93.
54. Caputo A, Caci E, Ferrera L, et al. TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity. Science 2008; 322: 590-594.
55. Rock JR, O'Neal WK, Gabriel SE, et al. Transmembrane protein 16A (TMEM16A) is a Ca 2+-regulated Cl secretory channel in mouse airways. J Biol Chem 2009; 284: 14875-14880.
56. Lohi H, Kujala M, Makela S, et al. Functional characterization of three novel tissue-specific anion exchangers SLC26A7,-A8, and-A9. J Biol Chem 2002; 277: 14246-14254.
57. Bertrand CA, Zhang R, Pilewski JM, et al. SLC26A9 is a constitutively active, CFTR-regulated anion conductance in human bronchial epithelia. J Gen Physiol 2009; 133: 421-438.
58. Loriol C, Dulong S, Avella M, et al. Characterization of SLC26A9, facilitation of Cl transport by bicarbonate. Cell Physiol Biochem 2008; 22: 15-30.
59. Anagnostopoulou P, Dai L, Schatterny J, et al. Allergic airway inflammation induces a pro-secretory epithelial ion transport phenotype in mice. Eur Respir J2010; 36: 1436-1447.
60. Anagnostopoulou P, Riederer B, Duerr J, et al. SLC26A9-mediated chloride secretion prevents mucus obstruction in airway inflammation. J Clin Invest 2012; 122: 3629-3634.
61. Sun L, Rommens JM, Corvol H, et al. Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis. Nat Genet 2012; 44: 562-569.
62. Bakouh N, Bienvenu T, Thomas A, et al. Characterization of SLC26A9 in patients with CF-like lung disease. Hum Mutat 2013; 34: 1404-1414.
63. Galietta LV, Jayaraman S, Verkman AS. Cell-based assay for high-throughput quantitative screening of CFTR chloride transport agonists. Am J Physiol Cell Physiol 2001; 281: C1734-C1742.
64. Van Goor F, Hadida S, Grootenhuis PD, et al. Rescue of CF airway epithelial cell functionin vitro by a CFTR potentiator, VX-770. Proc Natl Acad Sci USA2009; 106: 18825-18830.
65. Voynow JA, Fischer BM, Zheng S. Proteases and cystic fibrosis. Int J Biochem Cell Biol 2008; 40: 1238-1245.
66. Belaaouaj A, McCarthy R, Baumann M, et al. Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nat Med 1998; 4: 615-618.
67. Shapiro SD, Goldstein NM, Houghton AM, et al. Neutrophil elastase contributes to cigarette smoke-induced emphysema in mice. Am J Pathol 2003; 163: 2329-2335.
68. Hartl D, Latzin P, Hordijk P, et al. Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease. Nat Med 2007; 13: 1423-1430.
69. Caldwell RA, Boucher RC, Stutts MJ. Neutrophil elastase activates near-silent epithelial Na+ channels and increases airway epithelial Na+ transport. Am J Physiol Lung Cell Mol Physiol 2005; 288: L813-L819.
70. Gaillard EA, Kota P, Gentzsch M, et al. Regulation of the epithelial Na + channel and airway surface liquid volume by serine proteases. Pflugers Arch 2010; 460: 1-17.
71. Diakov A, Bera K, Mokrushina M, et al. Cleavage in thec-subunit of the epithelial sodium channel (ENaC) plays an important role in the proteolytic activation of near-silent channels. J Physiol 2008; 586: 4587-4608.
72. Haerteis S, Krappitz M, Bertog M, et al. Proteolytic activation of the epithelial sodium channel (ENaC) by the cysteine protease cathepsin-S. Pflugers Arch 2012; 464: 353-365.
73. Gentzsch M, Dang H, Dang Y, et al. The cystic fibrosis transmembrane conductance regulator impedes proteolytic stimulation of the epithelial Na+channel. J Biol Chem 2010; 285: 32227-32232.
74. Le Gars M, Descamps D, Roussel D, et al. Neutrophil elastase degrades cystic fibrosis transmembrane conductance regulator viacalpains and disables channel functionin vitro andin vivo. Am J Respir Crit Care Med 2013; 187: 170-179.
75. Matsui H, Davis CW, Tarran R, et al. Osmotic water permeabilities of cultured, well-differentiated normal and cystic fibrosis airway epithelia. J Clin Invest 2000; 105: 1419-1427.
76. Tarran R, Boucher RC. Thin-film measurements of airway surface liquid volume/composition and mucus transport ratesin vitro. Methods Mol Med 2002; 70: 479-492.
77. Wanner A, Salathe M, O'Riordan TG. Mucociliary clearance in the airways. Am J Respir Crit Care Med 1996; 154: 1868-1902.
78. Knowles MR, Boucher RC. Mucus clearance as a primary innate defense mechanism for mammalian airways. J Clin Invest 2002; 109: 571-577.
79. Mall MA. Role of cilia, mucus, and airway surface liquid in mucociliary dysfunction: lessons from mouse models. J Aerosol Med Pulm Drug Deliv 2008; 21: 13-24.
80. Button B, Cai LH, Ehre C, et al. A periciliary brush promotes the lung health by separating the mucus layer from airway epithelia. Science 2012; 337: 937-941.
81. Grubb BR, Paradiso AM, Boucher RC. Anomalies in ion transport in CF mouse tracheal epithelium. Am J Physiol 1994; 267: C293-C300.
82. Mall MA, Button B, Johannesson B, et al. Airway surface liquid volume regulation determines different airway phenotypes in liddle compared withbENaC-overexpressing mice. J Biol Chem 2010; 285: 26945-26955.
83. Hackett BP, Gitlin JD. Cell-specific expression of a Clara cell secretory protein-human growth hormone gene in the bronchiolar epithelium of transgenic mice. Proc Natl Acad Sci USA1992; 89: 9079-9083.
84. Pack RJ, Al Ugaily LH, Morris G. The cells of the tracheobronchial epithelium of the mouse: a quantitative light and electron microscope study. J Anat 1981; 132: 71-84.
85. Van Scott MR, Hester S, Boucher RC. Ion transport by rabbit nonciliated bronchiolar epithelial cells (Clara cells) in culture. Proc Natl Acad Sci USA1987; 84: 5496-5500.
86. Mall MA, Harkema JR, Trojanek JB, et al. Development of chronic bronchitis and emphysema inb-epithelial Na + channel-overexpressing mice. Am J Respir Crit Care Med 2008; 177: 730-742.
87. Livraghi A, Grubb BR, Hudson EJ, et al. Airway and lung pathology due to mucosal surface dehydration inbepithelial Na + channel-overexpressing mice: role of TNF-aand IL-4Rasignaling, influence of neonatal development, and limited efficacy of glucocorticoid treatment. J Immunol 2009; 182: 4357-4367.
88. Wielpütz MO, Eichinger M, Zhou Z, et al. In vivomonitoring of cystic fibrosis-like lung disease in mice by volumetric computed tomography. Eur Respir J2011; 38: 1060-1070.
89. Mall MA, Graeber SY, Stahl M, et al. Early cystic fibrosis lung disease: role of airway surface dehydration and lessons from preventive rehydration therapies in mice. Int J Biochem Cell Biol 2014 [In press DOI: 10. 1016/j. biocel. 2014. 02. 006].
90. Voynow JA, Gendler SJ, Rose MC. Regulation of mucin genes in chronic inflammatory airway diseases. Am J Respir Cell Mol Biol 2006; 34: 661-665.
91. Johannesson B, Hirtz S, Schatterny J, et al. CFTR regulates early pathogenesis of chronic obstructive lung disease in bENaC-overexpressing mice. PLoS One 2012; 7: e44059.
92. Livraghi-Butrico A, Kelly EJ, Wilkinson KJ, et al. Loss of CFTR function exacerbates the phenotype of Na + hyperabsorption in murine airways. Am J Physiol Lung Cell Mol Physiol 2013; 304: L469-L480.
93. Sun X, Olivier AK, Liang B, et al. Lung phenotype of juvenile and adult CFTR-knockout ferrets. Am J Respir Cell Mol Biol 2014; 50: 502-512.
94. Joo NS, Cho HJ, Khansaheb M, et al. Hyposecretion of fluid from tracheal submucosal glands of CFTR-deficient pigs. J Clin Invest 2010; 120: 3161-3166.
95. Hartl D, Gaggar A, Bruscia E, et al. Innate immunity in cystic fibrosis lung disease. J Cyst Fibros 2012; 11: 363-382.
96. Graeber SY, Zhou-Suckow Z, Schatterny J, et al. Hypertonic saline is effective in the prevention and treatment of mucus obstruction, but not airway inflammation, in mice with chronic obstructive lung disease. Am J Respir Cell Mol Biol 2013; 49: 410-417.
97. Zhou Z, Treis D, Schubert SC, et al. Preventive but not late amiloride therapy reduces morbidity and mortality of lung disease in bENaC-overexpressing mice. Am J Respir Crit Care Med 2008; 178: 1245-1256.
98. Grasemann H, Ratjen F. Early lung disease in cystic fibrosis. Lancet Respir Med 2013; 1: 148-157.
99. Hug MJ, Clarke LL, Gray MA. How to measure CFTR-dependent bicarbonate transport: from single channels to the intact epithelium. Methods Mol Biol 2011; 741: 489-509.
100. Coakley RD, Grubb BR, Paradiso AM, et al. Abnormal surface liquid pH regulation by cultured cystic fibrosis bronchial epithelium. Proc Natl Acad Sci USA2003; 100: 16083-16088.
101. Garcia MA, Yang N, Quinton PM. Normal mouse intestinal mucus release requires cystic fibrosis transmembrane regulator-dependent bicarbonate secretion. J Clin Invest 2009; 119: 2613-2622.
102. Gustafsson JK, Ermund A, Ambort D, et al. Bicarbonate and functional CFTR channel are required for proper mucin secretion and link cystic fibrosis with its mucus phenotype. J Exp Med 2012; 209: 1263-1272.
103. Quinton PM. Cystic fibrosis: impaired bicarbonate secretion and mucoviscidosis. Lancet 2008; 372: 415-417.